Form 8-K - Current report:
SEC Accession No. 0000950170-23-040569
Filing Date
2023-08-09
Accepted
2023-08-09 16:07:59
Documents
13
Period of Report
2023-08-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bttx-20230809.htm   iXBRL 8-K 58413
2 EX-99.1 bttx-ex99_1.htm EX-99.1 278321
  Complete submission text file 0000950170-23-040569.txt   472621

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bttx-20230809_lab.xml EX-101.LAB 13904
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bttx-20230809.xsd EX-101.SCH 2469
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bttx-20230809_pre.xml EX-101.PRE 10230
7 EXTRACTED XBRL INSTANCE DOCUMENT bttx-20230809_htm.xml XML 4860
Mailing Address 548 MARKET ST. #49404 SAN FRANCISCO CA 94101
Business Address 548 MARKET ST. #49404 SAN FRANCISCO CA 94101 415-887-2311
Better Therapeutics, Inc. (Filer) CIK: 0001832415 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39864 | Film No.: 231155162
SIC: 8000 Services-Health Services